Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
230.26
Nov 20 • 3:59 PM ET Dollar change-6.19 Percentage change(-2.62%)
Aftermarket Close
230.62
Aftermarket • 7:30 PM ET Dollar change+0.36 Percentage change(0.16%)
Index
RUI
Market Cap
14.78B
Enterprise Value
17.57B
Income
205.95M
Sales
4.72B
Book/sh
65.39
Cash/sh
44.50
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2890
IPO
Jun 01, 2007
P/E
78.10
Forward P/E
8.58
PEG
0.17
P/S
3.13
P/B
3.52
P/C
5.17
P/FCF
9.11
EV/EBITDA
9.31
EV/Sales
3.72
Quick Ratio
1.64
Current Ratio
1.82
Debt/Eq
1.35
LT Debt/Eq
1.10
Option/Short
Yes / Yes
EPS (ttm)
2.95
EPS next Y
26.84
EPS next Q
6.96
EPS this Y
78.21%
EPS next Y
79.74%
EPS next 5Y
49.27%
EPS past 3/5Y
-17.69% -
Sales past 3/5Y
5.26% 12.54%
EPS Y/Y TTM
161.19%
Sales Y/Y TTM
13.48%
EPS Q/Q
-283.08%
Sales Q/Q
10.38%
Insider Own
3.94%
Insider Trans
-7.48%
Inst Own
103.81%
Inst Trans
0.50%
ROA
1.76%
ROE
5.05%
ROIC
2.34%
Gross Margin
74.60%
Oper. Margin
24.77%
Profit Margin
4.37%
SMA20
0.19%
SMA50
0.66%
SMA200
3.78%
Trades
Shs Outstand
64.10M
Shs Float
61.66M
52W High
266.38 -13.56%
52W Low
156.95 46.71%
Volatility
3.71% 3.47%
ATR (14)
8.10
RSI (14)
48.75
Beta
0.32
Rel Volume
1.11
Avg Volume
890.43K
Volume
984,708
Perf Week
-4.67%
Perf Month
7.27%
Perf Quarter
-9.51%
Perf Half Y
-3.99%
Perf YTD
35.45%
Perf Year
31.02%
Perf 3Y
90.85%
Perf 5Y
79.37%
Perf 10Y
110.76%
Prev Close
236.45
Price
230.26
Change %
-2.62%
Consensus
Strong Buy
Avg. Price Target
$300.33
Implied Upside
+30.4%
Analysts13incl. previous ratings
Rating Distribution11 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 30, 2026Initiated
C logoCCitigroup
Buy$325+41.1%
Sep 24, 2026Resumed
GS logoGGoldman
Buy$337+46.4%
Jul 17, 2026Initiated
CCanaccord Genuity
Buy$290+25.9%
Jun 09, 2026Resumed
TFC logoTTruist
Buy$256+11.2%
May 22, 2026Initiated
BBernstein
Mkt Perform$229-0.5%
May 19, 2026Upgrade
UBS logoUUBS
Neutral → Buy$307+33.3%
Apr 10, 2026Resumed
RJF logoRRaymond James
Outperform$227-1.4%
Feb 27, 2026Initiated
BCS logoBBarclays
Overweight$224-2.7%
Nov 24, 2025Downgrade
UBS logoUUBS
Buy → Neutral$188-18.4%
Jul 15, 2025Initiated
DB logoDDeutsche Bank
Buy$152-34.0%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COZADD BRUCE CDirectorNov 06 '26Option Exercise136.1886,50011,779,570426,375Nov 10 04:46 PM
COZADD BRUCE CDirectorNov 06 '26Sale235.9568,80816,235,517357,567Nov 10 04:46 PM
Carr PatriciaSVP, Chief Accounting OfficerNov 04 '26Option Exercise140.031,250175,0387,925Nov 06 05:19 PM
Carr PatriciaSVP, Chief Accounting OfficerNov 04 '26Sale231.361,413326,9106,512Nov 06 05:19 PM
BRUCE COZADDDirectorNov 06 '26Proposed Sale235.9568,80816,235,516Nov 06 04:41 PM
GALA RENEE DPresident & CEONov 03 '26Sale225.371,000225,370140,394Nov 05 06:28 PM
COZADD BRUCE CDirectorNov 02 '26Sale215.846,0001,295,040339,875Nov 04 06:35 PM
PATRICIA CARROfficerNov 04 '26Proposed Sale231.361,413326,910Nov 04 04:05 PM
RENEE D GALAOfficerNov 03 '26Proposed Sale225.371,000225,370Nov 03 04:23 PM
Bruce C CozaddOfficerNov 02 '26Proposed Sale215.846,0001,295,040Nov 02 04:27 PM
ANNE O'RIORDANDirectorOct 08 '26Proposed Sale228.5514,6873,356,714Oct 08 04:04 PM
GALA RENEE DPresident & CEOOct 06 '26Sale236.402,000472,800141,394Oct 07 05:44 PM
RENEE D GALAOfficerOct 06 '26Proposed Sale236.402,000472,800Oct 06 04:20 PM
COZADD BRUCE CDirectorOct 01 '26Sale230.336,0001,381,980345,875Oct 05 04:18 PM
Bruce C CozaddOfficerOct 01 '26Proposed Sale230.336,0001,381,980Oct 01 04:32 PM
Patil Neena MEVP & Chief Legal OfficerSep 10 '26Sale240.941,200289,12847,671Sep 14 06:38 PM
GALA RENEE DPresident & CEOSep 08 '26Sale243.032,000486,060143,394Sep 10 04:33 PM
NEENA PATILOfficerSep 10 '26Proposed Sale240.941,200289,128Sep 10 04:06 PM
RENEE D GALAOfficerSep 08 '26Proposed Sale243.032,000486,060Sep 08 04:37 PM
Henderson Mary ElizabethDirectorSep 08 '26Proposed Sale246.812,691664,166Sep 08 02:27 PM
COZADD BRUCE CDirectorSep 01 '26Sale250.136,0001,500,780351,875Sep 02 05:03 PM
Bruce C CozaddOfficerSep 01 '26Proposed Sale250.136,0001,500,780Sep 01 04:21 PM
Iannone RobertEVP, Global Head of R&D & CMOAug 27 '26Option Exercise125.8457,5007,235,860142,607Aug 31 06:45 PM
Iannone RobertEVP, Global Head of R&D & CMOAug 27 '26Sale249.7076,92119,207,09865,686Aug 31 06:45 PM
LOVE TED WDirectorAug 31 '26Proposed Sale244.541,527373,413Aug 31 05:04 PM
Winningham Rick EDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 04:51 PM
Kennedy PatrickDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 04:42 PM
ENRIGHT PATRICK GDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 04:33 PM
RIEDEL NORBERT GDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 04:22 PM
Smith Mark DouglasDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 04:14 PM
Henderson Mary ElizabethDirectorAug 31 '26Proposed Sale244.543,852941,968Aug 31 03:50 PM
Hamill LauraDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 03:41 PM
Cook Jennifer E.DirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 03:36 PM
McSharry Heather AnnDirectorAug 31 '26Proposed Sale244.543,507857,602Aug 31 03:26 PM
COZADD BRUCE CDirectorAug 31 '26Proposed Sale244.542,506612,817Aug 31 03:10 PM
ROBERT IANNONEOfficerAug 27 '26Proposed Sale249.7076,92119,207,100Aug 27 04:31 PM
ORiordan AnneDirectorAug 07 '26Proposed Sale251.583,507882,291Aug 07 02:09 PM
COZADD BRUCE CDirectorAug 03 '26Sale252.986,0001,517,880360,682Aug 05 04:33 PM
Bruce C CozaddOfficerAug 03 '26Proposed Sale252.986,0001,517,880Aug 03 04:16 PM
COZADD BRUCE CDirectorJul 01 '26Sale240.476,0001,442,820366,682Jul 06 06:23 PM
Bruce C CozaddOfficerJul 01 '26Proposed Sale240.476,0001,442,820Jul 01 03:55 PM
Smith Mark DouglasDirectorJun 15 '26Sale230.551,157266,7469,680Jun 17 04:45 PM
MARK D SMITHDirectorJun 15 '26Proposed Sale230.551,157266,746Jun 15 04:09 PM
Patil Neena MEVP & Chief Legal OfficerJun 10 '26Sale231.831,200278,19651,549Jun 12 04:14 PM
NEENA PATILOfficerJun 10 '26Proposed Sale231.831,200278,196Jun 10 04:04 PM
COZADD BRUCE CDirectorJun 01 '26Sale235.126,0001,410,720372,682Jun 03 05:09 PM
Bruce C CozaddOfficerJun 01 '26Proposed Sale235.126,0001,410,720Jun 01 04:13 PM
Patil Neena MEVP & Chief Legal OfficerMay 28 '26Sale236.971,192282,46852,626Jun 01 04:09 PM
Pearce SamanthaEVP, Chief Commercial OfficerMay 28 '26Option Exercise109.456,907755,97157,179Jun 01 04:06 PM
Pearce SamanthaEVP, Chief Commercial OfficerMay 28 '26Sale235.416,9071,625,97750,272Jun 01 04:06 PM
Mulligan SeamusDirectorMay 28 '26Option Exercise138.083,415471,5431,183,028Jun 01 04:01 PM
NEENA PATILOfficerMay 28 '26Proposed Sale236.971,192282,468May 28 04:21 PM
SAMANTHA PEARCEOfficerMay 28 '26Proposed Sale235.416,9071,625,977May 28 04:18 PM
Winningham Rick EDirectorMay 22 '26Option Exercise138.083,415471,54312,308May 27 06:13 PM
Winningham Rick EDirectorMay 22 '26Sale241.572,741662,1439,567May 27 06:13 PM
McSharry Heather AnnDirectorMay 22 '26Sale241.002,000482,00018,449May 27 06:07 PM
HEATHER MCSHARRYDirectorMay 22 '26Proposed Sale241.002,000482,000May 22 04:27 PM
RICK WINNINGHAMDirectorMay 22 '26Proposed Sale241.572,741662,143May 22 04:13 PM
COZADD BRUCE CDirectorMay 01 '26Sale203.336,0001,219,980378,682May 05 04:27 PM
Bruce C CozaddOfficerMay 01 '26Proposed Sale203.336,0001,219,980May 01 03:44 PM
COZADD BRUCE CDirectorApr 01 '26Sale190.506,0001,143,010384,682Apr 03 05:09 PM
Bruce C CozaddOfficerApr 01 '26Proposed Sale190.506,0001,143,010Apr 01 04:03 PM
Carr PatriciaSVP, Chief Accounting OfficerMar 09 '26Sale182.941,287235,4446,512Mar 09 05:15 PM
PATRICIA CARROfficerMar 09 '26Proposed Sale182.941,287235,444Mar 09 04:26 PM
Carr PatriciaOfficerMar 05 '26Proposed Sale188.692,723513,803Mar 05 02:48 PM
Henderson Mary ElizabethOfficerFeb 26 '26Proposed Sale188.692,643498,708Mar 05 01:58 PM
COZADD BRUCE CDirectorMar 03 '26Sale186.446,0001,118,613405,796Mar 04 04:24 PM
Bruce C CozaddOfficerMar 03 '26Proposed Sale186.446,0001,118,613Mar 03 02:35 PM
RIEDEL NORBERT GDirectorFeb 27 '26Option Exercise138.083,415471,54310,439Mar 02 05:36 PM
RIEDEL NORBERT GDirectorFeb 27 '26Sale192.003,415655,6807,024Mar 02 05:36 PM
Carr PatriciaSVP, Chief Accounting OfficerFeb 26 '26Sale194.111,253243,22210,352Mar 02 05:14 PM
Carr PatriciaSVP, Chief Accounting OfficerFeb 27 '26Sale190.911,117213,2439,235Mar 02 05:14 PM
Patil Neena MEVP & Chief Legal OfficerFeb 26 '26Option Exercise127.2351,0006,488,70083,946Mar 02 05:06 PM
Patil Neena MEVP & Chief Legal OfficerFeb 26 '26Sale191.5655,60010,650,48256,862Mar 02 05:06 PM
Henderson Mary ElizabethSVP, Technical OperationsFeb 26 '26Sale194.495,3431,039,13428,728Mar 02 05:04 PM
PATRICIA CARROfficerFeb 27 '26Proposed Sale190.911,117213,243Feb 27 04:22 PM
NORBERT RIEDELDirectorFeb 27 '26Proposed Sale192.003,415655,680Feb 27 04:12 PM
NEENA PATILOfficerFeb 26 '26Proposed Sale191.5655,60010,650,480Feb 26 04:14 PM
Carr PatriciaOfficerFeb 26 '26Proposed Sale196.832,370466,487Feb 26 04:08 PM
Henderson Mary ElizabethOfficerFeb 26 '26Proposed Sale196.8310,1161,991,132Feb 26 03:48 PM
Henderson Mary ElizabethSVP, Technical OperationsDec 09 '25Sale169.512,238379,36619,508Dec 11 05:19 PM
MARY ELIZABETH HENDERSONOfficerDec 09 '25Proposed Sale169.512,238379,365Dec 09 06:52 PM
Carr PatriciaSVP, Chief Accounting OfficerDec 05 '25Option Exercise140.674,500633,01511,512Dec 09 05:25 PM
Carr PatriciaSVP, Chief Accounting OfficerDec 05 '25Sale171.204,660797,7837,012Dec 09 05:25 PM
PATRICIA CARROfficerDec 05 '25Proposed Sale171.204,660797,783Dec 05 04:03 PM
O'Keefe Kenneth WDirectorDec 02 '25Proposed Sale176.591,249220,561Dec 01 08:55 PM
COZADD BRUCE CDirectorNov 26 '25Option Exercise123.3677,5009,560,400470,832Dec 01 06:14 PM
COZADD BRUCE CDirectorNov 26 '25Sale177.8177,50013,780,337393,332Dec 01 06:14 PM
BRUCE COZADDDirectorNov 26 '25Proposed Sale177.8177,50013,780,337Nov 26 05:37 PM
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Co-Founder & ChairmanMr. Bruce C. Cozadd
PresidentMs. Renee D. Gala
Executive VP & CFOMr. Philip L. Johnson
Executive VP & Chief Legal OfficerMs. Neena M. Patil J.D.
Executive VPDr. Robert Iannone M.D.